Melatonin reduces torsion-detorsion injury in rat ovary: Biochemical and histopathologic evaluation

Journal of Pineal Research

Volumn 37, Issue 2, 2004, Pages 137-141

  Turkoz, Yusuf ^a,b   Celik, Onder ^a   Hascalik, Seyma ^a   Cigremis, Yilmaz ^a   Hascalik, Mehmet ^a   Mizrak, Bulent ^a   Yologlu, Saim ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Malondialdehyde; Melatonin; Ovarian torsion detorsion; Rat; Reduced glutathione; Xanthine oxidase

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; MELATONIN; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; ISCHEMIA; NEUTROPHIL; NONHUMAN; OVARY DISEASE; RAT; REPERFUSION INJURY; TISSUE LEVEL; TORSION; VASODILATATION;

ANIMALS; ANTIOXIDANTS; FEMALE; GLUTATHIONE; MALONDIALDEHYDE; MELATONIN; OVARY; RATS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; XANTHINE OXIDASE;

EID: 4344637037     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00146.x     Document Type: Article

References (49)

1. CHEN M, CHEN CD, YANG YS. Torsion of the previously normal uterine adnexa. Evaluation of the correlation between the pathological changes and the clinical characteristics. Acta Obstet Gynecol Scand 2001; 80:58-61.
2. HASKINS T, SHULL B. Adnexal torsion: a mind-twisting diagnosis. South Med J 1986; 79:576-577.
3. MEYER JS, HARMAN CM, HARTY MP et al. Ovarian torsion: clinical and imaging presentation in children. J Pediatr Surg 1995; 30:1433-1436.
4. KAAKAJI Y, NGHIEM HV, NODELL C et al. Sonography of obstetric and gynecologic emergencies: part II, gynecologic emergencies. Am J Roentgenol 2000; 174:651-656.
5. GILHAM B, PAPACHRISTODOULOU DK, THOMAS JH. Wills' Biochemical Basis of Medicine, 3rd edn. Butterworth-Heinemann, London; pp. 343-354.
6. BREEN AP, MURPHY JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995; 18:1033-1077.
7. AMES BN. Endogenous DNA damage as related to cancer and aging. Mutat Res 1989; 214:41-46.
8. TAN DX, CHEN LD, POEGGELLER B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
9. ALLEGRA M, REITER RJ, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
10. BERTUGLIA S, MARCHIAFAVA PL, COLANTUONI A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 1996; 31:947-952.
11. SEWERYNEK E, REITER RJ, MELCHIORRI D et al. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepato- Gastroenterology 1996; 43:898-905.
12. REITER RJ, TAN DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58:10-19.
13. CHEUNG RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 3-4:153-160.
14. UCHIYAMA M, MIHARA M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86:271-278.
15. ELLMAN GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82:70-77.
16. ROWE PB, WYNGAARDEN JB. The mechanism of dietary alterations in rat hepatic xanthine oxidase levels. J Biol Chem 1966; 241:5571-5576.
17. REITER RJ, TAN DX, MANCHESTER LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001; 34:237-256.
18. TAN DX, REITER RJ, MANCHESTER LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2:181-197.
19. REITER RJ, GUERRERO JM, GARCIA JJ et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci 1998; 854:410-424.
20. OKATANI Y. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000; 28:89-96.
21. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
22. CELIK H, AYAR A, TUG N et al. Effects of melatonin on noncardiogenic pulmonary edema secondary to adnexial ischemia-reperfusion in guinea pig. Neuroendocrinol Lett 2002; 23:115-118.
23. TORII K, UNEYAMA H, NISHINO H, KONDOH T. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J Pineal Res 2004; 36:18-24.
24. LAHIRI DK, GHOSH C. Interactions between melatonin, reactive oxygen species, and nitric oxide. Ann N Y Acad Sci 1999; 893:325-330.
25. SENER G, SEHIRLI AO, PASKALOGLU K, DULGER GA, ALICAN I. Melatonin treatment protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder. J Pineal Res 2003; 34:226-230.
26. SCUITO AM. Antioxidant properties of glutathione and its role in tissue protection. In: Oxidants, Antioxidants, and Free Radicals. Baskin SI, Salem H eds., Taylor and Francis, Washington, DC, 1997; pp. 171-191.
27. URATA Y, HONMA S, GOTO S et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999; 27:838-847.
28. HARA M, ABE M, SUZUKI T et al. Tissue changes in glutathione metabolism and lipid peroxidation induced by swimming are partially prevented by melatonin. Pharmacol Toxicol 1996; 78:308-312.
29. DURMUS O, ARICIOGLU A, GUVEN T et al. The effect of allopurinol on the liver ultrastructure, reduced glutathione and lipid peroxide levels during liver ischemia in guinea pigs. Gen Pharmacol 1994; 25:781-786.
30. MELCHIORRI D, REITER RJ, SEWERYNEK E et al. Paraquat toxicity and oxidative damage. Reduction by melatonin. Biochem Biochem Pharmacol 1996; 51:1095-1099.
31. REITER, RJ. Pineal melatonin: cell biology of its synthesis and its physiological interactions. Endocr Rev 1991; 12:151-156.
32. REITER RJ, CARNEIRO RC, OH CS. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 1997; 29:363-372.
33. MARSHALL KA, REITER RJ, POEGGELER B et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996; 21:307-315.
34. MELCHIORRI G, REITER RJ, ATTIA AM et al. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1994; 56:83-89.
35. DRAPER HH, HADLEY M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186:421-431.
36. KOLTUKSUZ U, OZEN S, UZ E et al. Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. J Pediatr Surg 1999; 34:1458-1462.
37. IRMAK MK, KOLTUKSUZ U, KUTLU NO et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 2001; 29:190-193.
38. VANECEK J. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78:687-721.
39. TAN DX, MANCHESTER LC, REITER RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998; 25:184-191.
40. SEWERYNEK E, ABE M, REITER RJ et al. Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem 1995; 58:436-444.
41. SEWERYNEK E, MELCHIORRI D, REITER RJ et al. Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995; 293:327-334.
42. SEWERYNEK E, MELCHIORRI D, CHEN L et al. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radic Biol Med 1995; 19:903-909.
43. HILLE R, NISHINO T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995; 9:995-1003.
44. BIRD JE, MILHOAN K, WILSON CB et al. Ischemic acute renal failure and antioxidant therapy in the rat: the relation between glomerular and tubular dysfunction. J Clin Invest 1988; 81:1630-1638.
45. RHODEN EL, RHODEN CR, MAURI M. Experimental model of renal ischemia-reperfusion in rats: study of the stress oxidative induced by oxygen-derived free radicals. Braz J Urol 1999; 25:431-436.
46. CHEN JC, NG CJ, CHIU TF et al. Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion. J Pineal Res 2003; 34:260-264.
47. 2+ in neonatal rat pituitary cells. Endocrinology 1992; 130:701-707.
48. MORGAN PJ, LAWSON W, DAVIDSON G et al. Melatonin inhibits cyclic AMP in cultured ovine pars tuberalis cells. J Mol Endocrinol 1989; 5:R3-R8.
49. JAESCHKE H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991; 79:115-136.